Active-ingredient Dossier

Meningococcal Polysaccharide Group C

Active-ingredient Dossier for Meningococcal Polysaccharide Group C (polysaccharide vaccine). Australian brands, products, PBS listings, PBAC outcomes —…

Brand: MenQuadfi
Brand: NEISVAC-C
Brand: NIMENRIX
Therapeutic area: Infectious Disease

What is

Meningococcal Polysaccharide Group C Meningococcal Polysaccharide Group C is a polysaccharide vaccine.

Australian brands containing

Meningococcal Polysaccharide Group C — MenQuadfi — NIMENRIX — NEISVAC-C

Therapeutic areas

Meningococcal Polysaccharide Group C is registered in Infectious Disease (2 brands) and Immunology (1 brand).

Sponsor landscape

Pfizer and Sanofi-Aventis market Meningococcal Polysaccharide Group C in Australia.

PBS and regulatory activity

The latest PBAC outcome for this ingredient was recorded on 1 March 2023, with 2 brands having PBAC outcomes on record. The latest AusPAR was published on 27 October 2020, with 1 brand having an AusPAR on record.